Tijaria Polypipes appoints new independent director, renews auditor at 20th AGM

2 min read     Updated on 07 Aug 2026, 04:32 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Tijaria Polypipes Limited held its 20th AGM on August 7, 2026, adopting FY26 financials and reappointing Praveen Jain Tijaria. Key changes include the appointment of Ms. Vishakha Saini as an independent director for five years and M/s Pramod & Associates as statutory auditor for one year, replacing the previous firm.

powered bylight_fuzz_icon
47646141

*this image is generated using AI for illustrative purposes only.

Tijaria Polypipes Limited concluded its 20th Annual General Meeting (AGM) on August 7, 2026, approving key governance changes including the appointment of a new independent director and a change in statutory auditors. The meeting, held at the company’s registered office in Jaipur, also saw shareholders adopt the financial statements for the fiscal year ended March 31, 2026. These appointments signal a refresh in the company’s oversight structure, with a focus on operational efficiency and compliance.

The proceedings were chaired by Alok Jain Tijaria, Managing Director and Chairman. Shareholders passed ordinary resolutions to receive and adopt the financial statements for FY26, along with the reports of the Board of Directors and Auditors. Additionally, Mr. Praveen Jain Tijaria (DIN: 00115002), who was liable to retire by rotation, was reappointed as a Director. The company also approved related party transactions as part of the special business agenda.

A significant governance update was the appointment of Ms. Vishakha Saini (DIN: 11800700) as a Non-Executive Independent Director. Her term is set for five years, effective from August 7, 2026. According to the company disclosure, Ms. Saini brings expertise in strategic planning and financial restructuring across various industries. She is expected to contribute significantly to improving operational efficiency. The filing confirms she has no relationship with any existing director of the company.

The company also replaced its statutory auditor. M/s Pramod & Associates, Chartered Accountants, Jaipur (FRN: 001557C), was appointed to fill the causal vacancy caused by the resignation of Amit Ramakant & Company. The new auditors will hold office for a period of one year, commencing from the conclusion of the 20th AGM until the conclusion of the 21st AGM in 2027. Their remuneration was fixed during the meeting.

Resolution Type Key Action Details
Ordinary Financial Approval Adoption of Financial Statements for FY26
Ordinary Director Reappointment Praveen Jain Tijaria reappointed
Ordinary Auditor Appointment M/s Pramod & Associates appointed for one year
Special Independent Director Ms. Vishakha Saini appointed for five years
Special Related Party Transactions Approved

The AGM commenced at 11:30 AM and concluded at 2:30 PM. Remote e-voting facilities were available from August 4, 2026, to August 6, 2026. Members present at the meeting who had not voted remotely were able to cast their votes via polling. The combined voting results and the Scrutinizer’s Report have been submitted to the stock exchanges and are available on the company’s website and NSDL.

Governance Updates

The appointment of Ms. Vishakha Saini adds strategic depth to the Board, particularly in financial restructuring. Her five-year tenure aligns with long-term planning cycles, potentially stabilizing director-level oversight during this period. Meanwhile, the shift in statutory auditors from Amit Ramakant & Company to M/s Pramod & Associates introduces a new audit perspective for the upcoming fiscal year. The firm, based in Jaipur, specializes in audit, operations, corporate governance, risk, and compliance services.

Historical Stock Returns for Tijaria Polypipes

1 Day5 Days1 Month6 Months1 Year5 Years
+7.38%+11.14%+17.55%-24.37%-42.74%-29.79%

How might Ms. Vishakha Saini's expertise in financial restructuring influence Tijaria Polypipes' capital allocation strategy or debt management in the coming fiscal year?

What specific operational efficiency targets has the board set that the new independent director is expected to help achieve during her five-year tenure?

Does the appointment of M/s Pramod & Associates as the new statutory auditor signal any anticipated changes in the company's compliance framework or risk assessment protocols?

Vardhman Jain Tijaria raises stake in Tijaria Polypipes to 4.33%

2 min read     Updated on 25 Jul 2026, 05:49 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Vardhman Jain Tijaria increased his stake in Tijaria Polypipes Limited to 4.3261% by buying 2,20,889 shares in the open market between February and March 2026. The revised disclosure filed on July 25, 2026, details nine separate transactions totaling 2,20,889 shares, raising his previous holding of 3.5545%. The company's total voting capital remains at 28,62,65,790 shares.

powered bylight_fuzz_icon
46527564

*this image is generated using AI for illustrative purposes only.

Tijaria Polypipes Limited disclosed on July 25, 2026, that Vardhman Jain Tijaria, a member of the promoter group, increased his equity stake in the company by acquiring 2,20,889 shares through open market transactions during February and March 2026. This acquisition raised his total holding from 1,017,549 shares (3.5545%) to 12,38,438 shares, representing a 4.3261% stake in the company’s total voting capital. The revised filing under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, was submitted to provide specific dates of acquisition rather than the broader monthly timeframe provided in the initial disclosure filed on April 1, 2026.

The acquisition occurred across nine distinct trading sessions between February 25, 2026, and March 23, 2026. The largest single-day purchase was recorded on March 17, 2026, when 70,000 shares were acquired. Other significant transactions included 32,000 shares on March 20, 2026, and 52,603 shares on March 9, 2026. The remaining purchases were smaller blocks, ranging from 104 shares on March 10, 2026, to 21,011 shares on March 23, 2026. No warrants, convertible securities, or voting rights other than shares were involved in these transactions, and no shares were encumbered with pledge or lien.

Acquisition Details

The following table outlines the specific open market transactions executed by Vardhman Jain Tijaria:

Date Shares Acquired
Feb 25, 2026 16,363
Mar 02, 2026 20,000
Mar 04, 2026 7,808
Mar 09, 2026 52,603
Mar 10, 2026 104
Mar 16, 2026 1,000
Mar 17, 2026 70,000
Mar 20, 2026 32,000
Mar 23, 2026 21,011
Total 2,20,889

Shareholding Structure

Prior to this acquisition, Vardhman Jain Tijaria held 1,017,549 shares, constituting 3.5545% of the company’s total share/voting capital. Following the purchase of 2,20,889 additional shares, his holding stands at 12,38,438 shares, or 4.3261% of the total voting capital. The company’s total equity share capital and diluted voting capital remained unchanged at 28,62,65,790 shares throughout the period. There were no changes in encumbered shares or voting rights held otherwise than by shares.

Regulatory Compliance

The initial disclosure regarding the acquisition was made on April 1, 2026, stating that the purchases occurred during the months of February and March 2026. The subsequent filing on July 25, 2026, serves as a revision to comply with Regulation 29(2) requirements for precise date reporting. Praveen Jain Tijaria, Whole Time Director of Tijaria Polypipes Limited, signed the communication addressed to the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. The acquirer, Vardhman Jain Tijaria, also signed the disclosure format confirming the details of the transaction and his status as part of the promoter group.

Historical Stock Returns for Tijaria Polypipes

1 Day5 Days1 Month6 Months1 Year5 Years
+7.38%+11.14%+17.55%-24.37%-42.74%-29.79%

What strategic rationale might drive Vardhman Jain Tijaria to increase his promoter stake from 3.55% to 4.33% amidst current market conditions?

Could this accumulation of shares signal an upcoming corporate action, such as a rights issue, buyback, or significant operational expansion for Tijaria Polypipes?

How might this increased promoter holding influence the company's stock price volatility and investor confidence in the short to medium term?

More News on Tijaria Polypipes

1 Year Returns:-42.74%